This study investigates pancreatic cancer. Researchers are examining how an investigational medication works when given with chemotherapy in people with this condition.
The study evaluates the effectiveness and safety of the investigational medication combined with chemotherapy. It looks at how the body processes the medication and checks for any side effects.
- Who can participate: Adults with metastatic pancreatic cancer and a specific KRAS G12D mutation can participate. Participants must have no option for surgery or radiotherapy and should have good organ function.
- Study details: Participants will receive either the investigational medication with chemotherapy or a placebo with chemotherapy.